Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone for deteriorating COVID-19 in primary care
NCT04746430Phase 4Terminated
- Sponsor
- General Practitioners Research Institute
- Start
- Feb 2021
- Primary completion
- Apr 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of dexamethasone in coronavirus disease 2019 (COVID-19), sponsored by General Practitioners Research Institute. Started Feb 2021; status: terminated.
02
Drugs
dexamethasone
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04746430.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04746430.